Refine by
Drug Conjugation Articles & Analysis: This-Year
7 articles found
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. ...
This article explores the mechanisms, benefits, challenges, and future prospects of PEGylation in drug development. Mechanism of PEGylation PEGylation involves the covalent or non-covalent attachment of PEG—a synthetic, hydrophilic polymer—to a drug molecule. The process typically uses reactive PEG derivatives (e.g., methoxy-PEG or ...
Despite these hurdles, biologics continue their rapid growth, with innovations like antibody-drug conjugates and bispecific antibodies expanding treatment possibilities for previously untreatable conditions. ...
Alfa Cytology has officially released its antibody-drug conjugates(ADCs) development services which demonstrates the dedication to fighting cancer through advanced treatment methods. Alfa Cytology, which stands at the forefront of oncology service provision in New York United States, has announced its sophisticated antibody-drug ...
Understanding Radioactive Drug Conjugates Radioactive drug conjugates are engineered to deliver radiation directly to cancer cells while sparing healthy tissues. ...
Research Tools: Researchers utilize single-domain antibodies in various applications, such as protein purification and label-free detection systems, due to their ability to bind specific targets with high affinity. Targeted Drug Delivery: Their small size allows them to be conjugated with drugs or therapeutic agents for targeted delivery, ...
Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, combining the specificity of antibodies with the potency of cytotoxic drugs. ...